Casdin Capital, LLC - Q3 2023 holdings

$904 Million is the total value of Casdin Capital, LLC's 40 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 22.0% .

 Value Shares↓ Weighting
SRPT SellSAREPTA THERAPEUTICS INC$122,472,203
+5.4%
1,010,330
-0.5%
13.56%
+33.4%
BLFS BuyBIOLIFE SOLUTIONS INC$107,441,800
-37.0%
7,780,000
+0.8%
11.89%
-20.3%
 EQRX INC$87,751,425
+19.4%
39,527,6690.0%9.71%
+51.2%
BuySTRUCTURE THERAPEUTICS INCsponsored ads$61,956,632
+49.5%
1,258,166
+26.2%
6.86%
+89.3%
RLAY BuyRELAY THERAPEUTICS INC$58,227,257
-22.7%
6,923,574
+15.4%
6.44%
-2.1%
RVMD  REVOLUTION MEDICINES INC$50,100,800
+3.5%
1,810,0000.0%5.54%
+31.1%
VERV BuyVERVE THERAPEUTICS INC$39,179,455
-11.5%
2,954,710
+25.2%
4.34%
+12.1%
NTLA SellINTELLIA THERAPEUTICS INC$37,250,732
-28.4%
1,178,075
-7.6%
4.12%
-9.3%
ALNY SellALNYLAM PHARMACEUTICALS INC$35,420,000
-33.4%
200,000
-28.6%
3.92%
-15.7%
EXAS SellEXACT SCIENCES CORP$31,343,679
-33.2%
459,450
-8.1%
3.47%
-15.5%
 SOMALOGIC INC$30,124,217
+3.5%
12,604,2750.0%3.33%
+31.1%
PLRX SellPLIANT THERAPEUTICS INC$27,347,053
-11.2%
1,577,108
-7.2%
3.03%
+12.4%
DNLI  DENALI THERAPEUTICS INC$26,819,000
-30.1%
1,300,0000.0%2.97%
-11.5%
MRTX BuyMIRATI THERAPEUTICS INC$21,711,480
+2423.4%
498,427
+1993.0%
2.40%
+3104.0%
BPMC SellBLUEPRINT MEDICINES CORP$18,650,603
-52.4%
371,378
-40.1%
2.06%
-39.7%
 TENAYA THERAPEUTICS INC$16,272,511
-56.6%
6,381,3770.0%1.80%
-45.0%
BuyTANGO THERAPEUTICS INC$14,720,750
+343.4%
1,307,349
+30.7%
1.63%
+461.7%
BEAM  BEAM THERAPEUTICS INC$13,708,500
-24.7%
570,0000.0%1.52%
-4.7%
FDMT Sell4D MOLECULAR THERAPEUTICS IN$13,160,414
-31.9%
1,033,811
-3.4%
1.46%
-13.8%
 GENEDX HOLDINGS CORP$11,267,660
-38.9%
3,095,5110.0%1.25%
-22.6%
ABCL SellABCELLERA BIOLOGICS INC$10,856,593
-33.3%
2,360,129
-6.3%
1.20%
-15.5%
PACB NewPACIFIC BIOSCIENCES CALIF IN$8,649,4231,035,859
+100.0%
0.96%
RNA BuyAVIDITY BIOSCIENCES INC$7,975,000
-15.4%
1,250,000
+47.1%
0.88%
+7.2%
 2SEVENTY BIO INC$7,933,739
-61.3%
2,023,9130.0%0.88%
-50.9%
IPSC  CENTURY THERAPEUTICS INC$6,412,760
-36.7%
3,206,3800.0%0.71%
-19.8%
SellMAXCYTE INC$5,896,800
-72.8%
1,890,000
-59.9%
0.65%
-65.5%
FATE  FATE THERAPEUTICS INC$4,346,000
-55.5%
2,050,0000.0%0.48%
-43.6%
ALNY NewALNYLAM PHARMACEUTICALS INCcall$3,542,00020,000
+100.0%
0.39%
 PRIME MEDICINE INC$3,502,850
-34.9%
367,1750.0%0.39%
-17.4%
FLDM  STANDARD BIOTOOLS INC$3,480,000
+50.3%
1,200,0000.0%0.38%
+90.6%
ILMN NewILLUMINA INCcall$3,432,00025,000
+100.0%
0.38%
ILMN SellILLUMINA INC$3,432,000
-88.2%
25,000
-83.9%
0.38%
-85.0%
SANA  SANA BIOTECHNOLOGY INC$2,902,500
-35.1%
750,0000.0%0.32%
-17.9%
GLUE  MONTE ROSA THERAPEUTICS INC$2,447,125
-30.1%
510,8820.0%0.27%
-11.4%
SellABSCI CORPORATION$1,284,703
-38.2%
973,260
-28.9%
0.14%
-22.0%
 EXSCIENTIA PLCads$966,828
-23.6%
213,9000.0%0.11%
-3.6%
CDXS NewCODEXIS INC$567,000300,000
+100.0%
0.06%
OMIC SellSINGULAR GENOMICS SYSTEMS IN$504,400
-54.8%
1,323,885
-1.6%
0.06%
-42.9%
 LIANBIOsponsored ads$307,558
-34.6%
206,4150.0%0.03%
-17.1%
KRON  KRONOS BIO INC$160,991
-24.4%
123,8390.0%0.02%
-5.3%
ExitSCILEX HOLDING CO$0-23,512
-100.0%
-0.01%
SAGE ExitSAGE THERAPEUTICS INC$0-90,000
-100.0%
-0.37%
INCY ExitINCYTE CORP$0-77,500
-100.0%
-0.42%
TWST ExitTWIST BIOSCIENCE CORP$0-450,000
-100.0%
-0.80%
CTLT ExitCATALENT INC$0-720,000
-100.0%
-2.73%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BLUEPRINT MEDICINES CORP32Q3 20239.6%
ALNYLAM PHARMACEUTICALS INC32Q3 20239.9%
AGIOS PHARMACEUTICALS INC27Q2 202212.1%
GLOBAL BLOOD THERAPEUTICS IN27Q2 20227.1%
FATE THERAPEUTICS INC26Q3 20238.3%
BIOLIFE SOLUTIONS INC22Q3 202314.9%
CODEXIS INC22Q3 20238.1%
SAREPTA THERAPEUTICS INC21Q3 202313.6%
BLUEBIRD BIO INC21Q4 20207.8%
ILLUMINA INC21Q3 20236.0%

View Casdin Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Casdin Capital, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Absci CorpMay 08, 20234,448,2604.8%
CODEXIS, INC.Sold outFebruary 14, 202300.0%
DermTech, Inc.Sold outFebruary 14, 202300.0%
Invitae CorpFebruary 14, 20239,038,3883.7%
Magenta Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Tango Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Verve Therapeutics, Inc.February 14, 20232,290,5713.7%
Tenaya Therapeutics, Inc.December 07, 20226,427,2009.9%
Century Therapeutics, Inc.October 11, 20223,206,3805.5%
Fulcrum Therapeutics, Inc.February 11, 20211,241,1764.5%

View Casdin Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-28
32024-03-25
42024-03-25
42024-03-20
SC 13D/A2024-03-20
42024-03-06
42024-03-06
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Casdin Capital, LLC's complete filings history.

Compare quarters

Export Casdin Capital, LLC's holdings